Lafutidine is a new type antiulcer agent with antisecretory and gastroprote
ctive activities. We investigated the effect of lafutidine on indomethacin-
induced antral ulcer in refed rats. Subcutaneous indomethacin injection res
ulted in the formation of gastric antral ulcer. Lafutidine (1-10 mg/kg, p.o
.) reduced the area of ulcer in a dose-dependent manner when administered i
mmediately after the indomethacin injection. Capsaicin at 3 mg/kg, p.o. and
16,16-dimethyl prostaglandin Ea at 3 mu g/kg, p.o. also reduced the ulcer
area. Chemical deafferentation of capsaicin-sensitive neurons or N-G-nitro-
L-arginine treatment aggravated the ulcer formation and abolished the preve
ntive effect of lafutidine and capsaicin. After the induction of gastric ul
cer, lafutidine given twice daily for 2.5 days reduced the area of ulcer in
a dose-dependent manner with a significant effect at 10 mg/kg, p.o., as co
mpared with that of the control group. In chemically-deafferentated rats, l
afutidine did not show any healing effect. Cimetidine (30 mg/kg, p.o.) and
famotidine (1 mg/kg, p.o.) had no significant effect on indomethacin-induce
d antral ulcer. These results may suggest that lafutidine, unlike cimetidin
e and famotidine, can prevent the indomethacin-induced antral ulcer formati
on and accelerate the healing of the ulcer in refed rats through mechanisms
involving the capsaicin-sensitive afferent neurons and nitric oxide.